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Inflammatory processes play essential roles in the pathogen-
esis of tendinitis and tendinopathy. These events are accompa-
nied by catabolic processes initiated by pro-inflammatory cyto-
kines such as interleukin-1 (IL-1) and tumor necrosis
factor- (TNF-). Pharmacological treatments for tendinitis
are restricted to the use of non-steroidal anti-inflammatory
drugs. Recent studies in various cell models have demonstrated
that curcumin targets the NF-B signaling pathway. However,
its potential for the treatment of tendinitis has not been
explored. Herein, we used an in vitromodel of human tenocytes
to study the mechanism of curcumin action on IL-1-mediated
inflammatory signaling. Curcumin at concentrations of 5–20
M inhibited IL-1-induced inflammation and apoptosis in cul-
tures of human tenocytes. The anti-inflammatory effects of cur-
cumin included down-regulation of gene products that mediate
matrix degradation (matrix metalloproteinase-1, -9, and -13),
prostanoid production (cyclooxygenase-2), apoptosis (Bax and
activated caspase-3), and stimulation of cell survival (Bcl-2), all
known to be regulated by NF-B. Furthermore, curcumin sup-
pressed IL-1-induced NF-B activation via inhibition of phos-
phorylation and degradation of inhibitor of B, inhibition of
inhibitor of B-kinase activity, and inhibition of nuclear trans-
location of NF-B. Furthermore, the effects of IL-1were abro-
gated bywortmannin, suggesting a role for the phosphatidylino-
sitol 3-kinase (PI-3K) pathway in IL-1 signaling. Curcumin
suppressed IL-1-induced PI-3K p85/Akt activation and its
association with IKK. These results demonstrate, for the first
time, a potential role for curcumin in treating tendon inflamma-
tion through modulation of NF-B signaling, which involves
PI-3K/Akt and the tendon-specific transcription factor scleraxis
in tenocytes.
The global incidence of tendon injuries has increased in con-
junction with the rise in aging and inflammatory diseases (1).
The etiology of tendinopathy is considered to bemultifactorial,
but mechanical loading, overuse injury (or association with
arthritis), adverse effects of quinolone antibiotics or other
drugs, degeneration, and inflammation that cause tendon inju-
ries and rupture are the major causative factors (2–5). Teno-
cytes are embedded in an extensive three-dimensional network
of extracellular matrix components consisting predominantly
of collagen type I fibrils (95% of the total collagen in tendon),
other types of collagen (type III and type V), proteoglycans,
elastin, and fibronectin (6–8). These specific matrix compo-
nents give tendon its resilience and biomechanical stability.
Tendon and ligament are dense fibrous connective tissues
with a very limited intrinsic potential for regeneration (7, 9).
Therefore, their repair and regeneration poses a complex clin-
ical challenge. It is important to understand the cellular and
molecularmechanisms involved in tendondegeneration during
the early stages of disease pathogenesis to develop new and
effective treatments for tendinopathy. Subtle changes such as
the release of IL-1 or other inflammatory cytokines by infil-
trating macrophages/monocytes may occur (10). Moreover,
like in other connective tissue injuries, tendon inflammation is
accompanied by the up-regulation of pro-inflammatory cyto-
kines such as IL-1. In vitro studies have shown that IL-1 can
induce inflammatory mediators such as COX-2, prostaglandin
E2, and matrix metalloproteinases (MMP),3 all known to be
involved in tendon matrix degradation (11, 12).
IL-1 is a potent pro-inflammatory cytokine that has been
reported to be present in significantly increased quantities in
the synovium where it enhances inflammatory reactions in
injured joints (13, 14). The intracellular signaling pathways
activated by IL-1 are responsible for stimulatingMMPexpres-
sion andCOX-2production.However, these pathways have not
been explored in detail in tendon cells. Pro-inflammatory cyto-
kines (e.g. IL-1) induce activation of a central transcription
factor known asNF-B, which is a key regulator of gene expres-
sion (15, 16). NF-B is present in the cytoplasm in its resting
stage as a heterotrimer complex consisting of two subunits and
an additional inhibitory subunit, IB (17). During the activa-
tion process, the inhibitory subunit IB is phosphorylated at
Author’s Choice—Final version full access.
1 Supported by the Biotechnology and Biological Sciences Research Council
(BBSRC) and The Wellcome Trust, UK.
2 Towhom correspondence should be addressed: Institute of Anatomy,Mus-
culoskeletal Research Group, Ludwig-Maximilian-University Munich,
Pettenkoferstrasse 11, D-80336 Munich, Germany. Tel.: 49-89-5160-4827;
Fax: 49-89-5160-4828; E-mail: mehdi.shakibaei@med.uni-muenchen.de.
3 The abbreviations used are: MMP, matrix metalloproteinase; IKK, IB
kinase; SCXA, scleraxis; TRAF1, TNF receptor-associated factor 1.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 286, NO. 32, pp. 28556–28566, August 12, 2011
Author’s Choice © 2011 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
28556 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 32•AUGUST 12, 2011
Ser-32 and Ser-36 residues by IKK kinase (IB kinase) and is
subsequently degraded. Once released, subunits of activated
NF-B translocate to the nucleus and mediate transcription of
various inflammatory and catabolic gene products (16, 18).
NF-B activation has been shown to regulate the expression of
more than 500 different gene products linked with inflamma-
tion, tumor cell transformation, survival, proliferation, inva-
sion, angiogenesis, metastasis, and chemoresistance (19). Thus,
inhibitors of NF-B activation may have therapeutic potential
and are actively being researched.
Non-steroidal anti-inflammatory drugs are commonly pre-
scribed for the treatment of tendinitis (20). However, the use of
non-steroidal anti-inflammatory drugs is associated with
numerous side effects, which can be quite adverse. Therefore,
the search is still on for safer andmore selective pharmacother-
apies for tendinopathy. Curcumin (diferuloylmethane) is a nat-
urally occurring polyphenol derived from the rhizome of Cur-
cuma longa Linn, with the potential for treatment of various
diseases acting via NF-B inhibition (21–23). Commercially
available preparations of curcumin contain three major com-
ponents: curcumin (77%), demethoxycurcumin (17%), and bis-
demethoxycurcumin (3%), altogether referred to as the “cur-
cuminoids” (22, 24–28). Recent studies have shown that
curcumin mediates its effects by modulation of several impor-
tant molecular targets, including transcription factors (e.g.
NF-B,AP-1,-catenin, and peroxisomeproliferator-activated
receptor-), enzymes (e.g. COX-2, 5-LOX, and iNOS), pro-in-
flammatory cytokines (e.g. TNF-, IL-1, and IL-6), and cell
surface adhesion molecules. Because of its ability to modulate
the expression of these targets, the therapeutic potential of cur-
cumin for treating cancer, arthritis, diabetes, Crohn disease,
cardiovascular diseases, osteoporosis, Alzheimer disease, pso-
riasis, and other pathologies is now under investigation (24, 28,
29). Furthermore, curcumin has been studied in clinical trials
for its anti-inflammatory, anti-carcinogenic, and free radical
scavenger properties (22). Phase I clinical trials have indicated
that human subjects can tolerate curcumin doses as high as
8–12 g/day with no adverse side effects (30, 31). Moreover,
several aspects of the pharmacological properties and the use of
curcumin for cancer chemoprevention have been reviewed
recently (32). Although curcumin is a potent inhibitor of
NF-B, its effects on human tenocytes have not been investi-
gated at the cellular or molecular levels.
Phosphatidylinositol 3-kinases (PI-3Ks) are a highly con-
served family of kinases that catalyze the 3-position of the ino-
sitol ring of phosphoinositides to generate phosphatidylinositol
3-phosphate, phosphatidylinositol 3,4-bisphosphate, and phos-
phatidylinositol 3,4,5-trisphosphate (33). PI-3K is a heterodi-
meric lipid kinase consisting of an 85-kDa regulatory subunit
and a 110-kDa catalytic subunit that plays a pivotal role in cell
movement, growth, vesicular trafficking, mitogenesis, and cell
survival (34, 35). PI-3K is involved in the IL-1 signaling path-
way and mediates activation and translocation of NF-B
through targeting IKK- or phosphorylation of p65, a process
that is inhibited by the PI-3K-specific inhibitor wortmannin
(36, 37). Several reports suggest that PI-3K activates protein
kinase B (Akt), one of themain downstream kinases in cells (33,
38). However, the PI-3K/Akt signaling pathway has not yet
been implicated in the activation of NF-B in tenocytes.
The aim of this study was to exploit an in vitro model of
human tenocytes to study themechanism of curcumin in IL-1
signaling and investigate whether curcumin might antagonize
the catabolic effects of pro-inflammatory cytokines by sup-
pressing NF-B-activation and NF-B-induced gene expres-
sion. We also explored the molecular mechanisms by which
curcumin suppresses NF-B activation in tenocytes, a process
that was partly mediated by the PI-3K/Akt signaling pathway.
EXPERIMENTAL PROCEDURES
Antibodies—The following antibodies were purchased from
Chemicon International, Inc. (Temecula, CA): polyclonal anti-
collagen type I, polyclonal anti-collagen type III, polyclonal
anti-decorin antibody, and alkaline phosphatase linked sheep
anti-mouse and sheep anti-rabbit secondary antibodies for
immunoblotting. Polyclonal anti-active caspase-3was obtained
from R&D Systems. Monoclonal antibody to -actin, and pro-
tein A/G-Sepharose beads were from Sigma. Polyclonal anti-
tenomodulin (sc-49325) and anti-phosphatidylinositol 3-ki-
nase (PI-3K) p85 antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Polyclonal anti-scleraxis
(SCXA) (ab58655) was obtained from Abcam (Cambridge,
UK). Polyclonal anti-active caspase-3 (AF835) was purchased
from R&D Systems. Antibodies against phospho-specific IB
(Ser-32/36) and against anti-phospho-specific p65 (NF-B)/
(Ser-536) were obtained from Cell Technology (Beverly, MA).
Anti-IB kinase (anti-IKK)- and (anti-IKK)- antibodies were
obtained from Imgenex (Hamburg, Germany). All antibodies
were used at concentrations and dilutions recommended by the
manufacturer (dilutions ranged from 1:100 for immunomor-
phological experiments to 1:10,000 for Western blot analysis).
Secondary antibodies for immunofluorescence were purchased
from Dianova (Hamburg, Germany).
Growth Medium and Chemicals—Growth medium (Ham’s
F-12/Dulbecco’s modified Eagle’s medium (50/50) containing
10% fetal calf serum (FCS), 25 g/ml of ascorbic acid, 50 IU/ml
of streptomycin, 50 IU/ml of penicillin, 2.5g/ml of amphoter-
icin B, essential amino acids, and L-glutamine) was obtained
from Seromed (Munich, Germany). Trypsin/EDTA (EC
3.4.21.4) and wortmannin were purchased from Sigma. Epon
was obtained from Plano (Marburg, Germany). Curcumin with
a purity of greater than 95% was purchased from Indsaff (Pun-
jab, India). Curcumin was dissolved in dimethyl sulfoxide as a
stock concentration of 500 M and stored at 80 °C. Serial
dilutions were prepared in culture medium. Curcumin was
diluted in dimethyl sulfoxide as a 5000 M concentration and
then further diluted in cell culturemedium. IL-1was obtained
from Acris Antibodies GmbH (Herold, Germany).
Tenocyte Isolation and Culture—The peritendineum of
human tendon explants (healthy finger tendon of one male
middle-aged donor), obtained during tendon-rupture surgery,
was carefully removed before culturing in growth medium
(Ham’s F-12/Dulbecco’s modified Eagle’s medium (50/50)) for
several days (39). Tendon samples were derived from patients
with full informed consent and local ethics committee
approval. After 1–2 weeks, tenocytes continuously migrated
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from this explant and adhered to Petri dishes. Tendon cells
were trypsinized and expanded in monolayers to gain a suffi-
cient number of cells for the experiments described.
Experimental Design—Tenocyte monolayer cultures were
washed three times with serum-starvedmedium and incubated
for 1 h with serum-starved medium (3% FCS). Serum-starved
human tenocytes were either left untreated or treated with 10
ng/ml of IL-1 alone for the indicated time periods or pre-
treated with 5 M curcumin or 5 M curcumin for 4 h followed
by co-treatment with 10 ng/ml of IL-1 and 5M curcumin for
the indicated time periods. For investigation of NF-B translo-
cation and IB phosphorylation, primary tenocyte monolayer
cultures were washed three times with serum-starved medium
and incubated for 1 h with serum-starved medium (3% FCS).
The cells were then either treated with 5M curcumin or 20 nM
wortmannin or pre-treated with 5M curcumin or 20 nMwort-
mannin for 0, 5, 10, 20, 40, and 60 min, followed by stimulation
with 10 ng/ml of IL-1 for 30 min. In separate experiments,
tenocytes were preincubated with curcumin or wortmannin at
the indicated concentrations for 4 h followed by co-treatment
with 10 ng/ml of IL-1 and curcumin or wortmannin for 30
min. Nuclear and cytoplasmic extracts were then prepared as
described later. These experiments were performed in tripli-
cate and the results are provided as mean values from three
independent experiments.
Immunofluorescence Analysis of NF-B (p65) Localization—
The effect of curcumin on the nuclear translocation of p65 was
investigated by an immunocytochemical method as previously
described in detail (28). Briefly, human tenocytes were cultured
on glass coverslips and incubated for 24 h. Serum-starved
human tenocytes were treated with 10 ng/ml of IL-1 or 5 M
curcumin, or were pre-treated with 5 M curcumin for 4 h and
then co-treated with 10 ng/ml of IL-1 and curcumin for 30
min in serum-starved medium. Glass coverslips with tenocyte
monolayers were rinsed three times in Hanks’ solution before
methanol fixation for 10min at ambient temperature, and rins-
ing with PBS. Cell and nuclear membranes of tenocytes were
permeabilized by treatment with 0.1% Triton X-100 for 1 min
on ice. Cells were overlaid with protease-free bovine serum
albumin (BSA) for 10 min at ambient temperature, rinsed with
PBS, and incubatedwith primary antibodies (phospho-p65) in a
humid chamber overnight at 4 °C. They were gently washed
several times with PBS before incubation with rhodamine red-
conjugated secondary antibody for 2 h at ambient temperature
and finally washed again three times with Aqua dest. Counter-
staining was performed with DAPI to visualize the cell nuclei.
Samples were evaluated by light microscopy (Leica, Germany)
and photomicrographs were digitally captured and stored.
Western Blot Analysis—For Western blot analysis proteins
were extracted from the monolayer cultures with lysis buffer
(50mMTris-HCl, pH 7.2, 150mMNaCl, 1% (v/v) Triton X-100,
1 mM sodium orthovanadate, 50 mM sodium pyrophosphate,
100mM sodium fluoride, 0.01% (v/v) aprotinin, 4g/ml of pep-
statin A, 10 g/ml of leupeptin, 1 mM phenylmethylsulfonyl
fluoride, PMSF) on ice for 30 min as previously described (40).
Total protein concentration was measured with the bicincho-
nic acid assay system (Uptima,Monlucon, France) using bovine
serum albumin as a standard. Samples were further reduced
with 2-mercaptoethanol and equal quantities of protein (500
ng/lane), separated under reducing conditions by SDS-PAGE
using 5, 7.5, 10, and 12%gels and transferred onto nitrocellulose
membranes using a transblot apparatus (Bio-Rad). After prein-
cubation in blocking buffer (5% skimmed milk powder in PBS,
0.1% Tween 20) for 1 h, membranes were incubated with pri-
mary antibodies at 4 °C overnight, washed three times with
blocking buffer, and then further incubated with alkaline phos-
phatase-conjugated secondary antibodies for 2 h at ambient
temperature. After further washing in 0.1 M Tris, pH 9.5, con-
taining 0.05 MMgCl2 and 0.1 MNaCl, specific antigen-antibody
complexes were detected using nitro blue tetrazolium and
5-bromo-4-chloro-3-indoylphosphate (p-toluidine salt; Pierce).
Transmission Electron Microscopy—Electron microscopy
was performed as previously described (41). Briefly, monolayer
cultures were fixed for 1 h in Karnovsky fixative followed by
post-fixation in 1% OsO4 solution. After dehydration in an
ascending alcohol series, pellets were embedded in Epon and
cut ultrathin with a Reichert-Jung Ultracut E (Darmstadt, Ger-
many). Sections were contrasted with a mixture of 2% uranyl
acetate/lead citrate and examined with a transmission electron
microscope (TEM 10, Zeiss, Jena, Germany).
Isolation of Tenocyte Cytoplasmic and Nuclear Extracts—
Isolation of tenocyte cytoplasmic and nuclear extracts was per-
formed as previously described (29). Briefly, tenocytes were
trypsinized and washed twice in 1 ml of ice-cold PBS. The
supernatant was carefully removed. The cell pellet was resus-
pended in hypotonic lysis buffer containing protease inhibitors
and was incubated on ice for 15 min. Then 12.5 l of 10%Non-
idet P-40 was added and the cell suspension was vigorously
mixed for 15 s. The extracts were centrifuged for 1.5 min. The
supernatants (cytoplasmic extracts) were frozen at 70 °C. 25
l of ice-cold nuclear extraction buffer were added to the pel-
lets and incubated for 30 min with intermittent mixing.
Extracts were centrifuged, and the supernatant (nuclear
extracts) was transferred to pre-chilled tubes for storage at
70 °C.
Immune Complex Kinase Assay—To test the effect of curcu-
min on IL-1-induced IKK activation, immune complex kinase
assays were performed as previously described (29). The IKK
complex was immunoprecipitated from whole cell lysates with
antibodies against IKK- and IKK- and subsequently incu-
bated with protein A/G-agarose beads (Pierce). After 2 h of
incubation, the beads were washed with lysis buffer and resus-
pended in a kinase assay solution containing 50mMHEPES, pH
7.4, 20 mM MgCl2, 2 mM dithiothreitol, 10 M unlabeled ATP,
and 2 mg of substrate GST-IB (amino acids 1 to 54), and
incubated at 30 °C for 30 min. Phosphorylation of GST-IB
was assessed using a specific antibody against phospho-specific
IB (Ser-32/36). To demonstrate the total amounts of IKK-
and IKK- in each sample, whole cell lysateswere transferred to
a nitrocellulose membrane after SDS-PAGE under reducing
conditions as described above. Detection of IKK- and IKK-
was performed by immunoblotting with either anti-IKK- or
anti-IKK- antibodies.
Immunoprecipitation of p65 and p65 Acetylation Assay—To
examine the effect of curcumin on IL-1-induced acetylation of
p65, tenocytes were pre-treatedwith 5M curcumin for 4 h and
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then exposed to 10 ng/ml of IL-1 for the indicated times. The
cells were washed with ice-cold phosphate-buffered saline
(PBS), and lysed in a buffer containing 50mMTris-HCl, pH 7.2,
150 mMNaCl, 1% (v/v) Triton X-100, 1 mM sodium orthovana-
date, 50 mM sodium pyrophosphate, 100 mM sodium fluoride,
0.01% (v/v) aprotinin, 4 g/ml of pepstatin A, 10 g/ml of leu-
peptin, 1 mM phenylmethylsulfonyl fluoride (PMSF) to prepare
whole cell lysates.Whole cell extracts were pre-cleared by incu-
bating with 25 l of either normal rabbit IgG serum or normal
mouse IgG serum and protein A/G-Sepharose beads, then with
primary antibodies (anti-p65 antibody) appropriately diluted in
wash buffer (0.1% Tween 20, 150 mM NaCl, 50 mM Tris-HCl
(pH 7.2), 1 mM CaCl2, 1 mMMgCl2, and 1 mM PMSF) for 2 h at
4 °C. After 1 h of incubation, immunocomplexes were washed
with lysis buffer, boiled with SDS sample buffer for 5 min,
resolved on SDS-PAGE, and subjected toWestern blot analysis
using an anti-acetyl-lysine antibody.
Pharmacological Experiments with Wortmannin—Teno-
cytes were grown in growth medium for 24 h. PI-3K inhibition
experiments were carried out in serum-starvedmedium. Teno-
cytes were pre-treated for 1 hwith serum-starvedmedium con-
tainingwortmannin (1, 10, and 20 nM) for 1 h, treatedwith 5M
curcumin for 4 h, and then exposed to 10 ng/ml of IL-1 for 1 h.
After these treatments, nuclear extracts were prepared and
examined for NF-B as described above.
Statistical Analysis—The optical density (specific binding) of
each protein band was measured and semiquantitatively ana-
lyzed using the Quantity One software package (Bio-Rad). The
results are shown as the mean S.D. of a representative exper-
iment performed in triplicate.
RESULTS
Cell Culture—This study was undertaken to investigate the
effect of curcumin on the PI-3K/Akt signaling pathway leading
to activation of the transcription factor NF-B signaling path-
way and on NF-B-regulated gene products in human teno-
cytes in an in vitro model of tendinopathy. Tenocytes treated
with curcumin (5–20M) orwortmannin (1–40nM) showedno
signs of cytotoxic effects or any negative effects on cell viability
(data not shown) at the light microscopic and ultrastructural
levels. To examine the effect of curcumin on the NF-B activa-
tion pathway, we used IL-1 because the pathway activated by
this cytokine is relatively well understood.
Curcumin Inhibits IL-1-induced Degenerative Features and
Apoptosis in Tenocytes—Untreated monolayer tenocytes
exhibited typically flattened shapeswith small cytoplasmic pro-
cesses, largemostly euchromatic nuclei with nucleoli and awell
structured cytoplasm (Fig. 1A,a). Treatment of tenocytemono-
layer cultures with 10 ng/ml of IL-1 for 12, 24, and 48 h led to
degenerative changes such as multiple vacuoles, swelling of
rough endoplasmic reticulum, and clustering of swollen mito-
chondria, condensed heterochromatin in the cell nuclei, and
multiple autophagic cytoplasmic vacuoles. The flattened
monolayer tenocytes became more and more rounded, lost
their microvilli-like processes, and became apoptotic (Fig. 1A,
b–d).
Tenocytes that were pretreatedwith curcumin (4 h) and then
co-treated with IL-1 and 5 M curcumin for 12, 24, and 48 h
showed less severe cellular degeneration at the ultrastructural
level as early as 12 h after co-treatment (Fig. 1A, e–g). The
tenocytes regained a flattened shape and numerous microvilli-
like cytoplasmic processes.
Statistical evaluation of the data clearly highlighted changes
in the number of cells with mitochondrial changes before and
after IL-1-treatment. Co-treatment with curcumin clearly
decreased the number of cells with mitochondrial changes
(Fig. 1B).
Effect of Curcumin on IL-1-induced Inhibition of Extracellular
Matrix and Signaling Protein Expression in Tenocytes—Serum-
starved human tenocytes were cultured for 24 h and then
treated with 10 ng/ml of IL-1 or 5 M curcumin or were pre-
treated with 5M curcumin for 4 h and then co-treated with 10
ng/ml of IL-1 and curcumin or left untreated and evaluated
after 24 h. Western blotting was performed by probing whole
cell lysates with antibodies against collagen types I and III,
decorin, tenomodulin, and the tendon-specific transcription
factor SCXA (Fig. 2). Primary human tenocytes stimulatedwith
IL-1 alone showed a significant down-regulation of synthesis
of collagen types I, III, decorin, tenomodulin, and SCXA
expression (Fig. 2). In contrast, pre-treatment of tenocytes with
curcumin followed by stimulation with IL-1 resulted in an
inhibition of cytokine-induced effects on the above mentioned
protein production (Fig. 2). Synthesis of the housekeeping protein
-actin remained unaffected (Fig. 2).
Curcumin Inhibits IL-1-induced NF-B-dependent Pro-
inflammatory and Matrix Degradation Gene Products in
Tenocytes—We examined whether curcumin canmodulate the
expression of IL-1-induced NF-B-regulated gene products
involved in the inflammatory and degradative processes in
tenocytes. Primary human tenocytes with or without pre-treat-
ment with curcumin were examined for IL-1-induced gene
products by Western blot analysis using specific antibodies
(Fig. 3A). IL-1 induced the expression of COX-2, MMP-1,
MMP-9, and MMP-13, but treatment with curcumin inhibited
the expression of these proteins in primary tenocytes (Fig. 3A).
Effect of Curcumin on IL-1-inducedNF-B-dependent Anti-
apoptotic and Pro-apoptotic Gene Products in Tenocytes—It is
known that NF-B regulates the expression of anti-apoptotic
proteins Bcl-2, Bcl-xL, and TRAF1 (TNF receptor-associated
factor 1) (42, 43).We investigated whether curcumin canmod-
ulate the expression of these anti-apoptotic gene products.
IL-1-stimulated primary human tenocytes were examined by
Western blot analysis with or without curcumin pre-treatment
(Fig. 3B). As shown in Fig. 3B, IL-1 inhibited the expression of
Bcl-2, Bcl-xL, and TRAF1 in a time-dependentmanner. In con-
trast, curcumin stimulated the expression of these anti-apo-
ptotic proteins (Fig. 3B). To determine whether curcumin
inhibits the IL-1-induced pro-apoptotic gene product, Bax
and activated caspase-3, in the same cell cultures, tenocytes
were incubated with IL-1 (10 ng/ml) alone for the indicated
time or preincubated with curcumin (5 M) for 4 h and then
co-treated with IL-1 (10 ng/ml) for the indicated time. As
shown in Fig. 3C, pre-treatment with curcumin significantly
down-regulated the level of Bax and biologically active
caspase-3 in IL-1-stimulated cultures compared with human
tenocytes stimulated with IL-1 alone.
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Curcumin Suppresses IL-1-induced Activation and Nuclear
Translocation of NF-B in a Concentration- and Time-depen-
dent Manner in Tenocytes—To evaluate whether curcumin
inhibits the IL-1-induced activation and nuclear translocation
of NF-B, nuclear protein extracts from serum-starved teno-
cytes were probed for the phosphorylated form of the p65
NF-B subunit after either the cells were stimulated with 10
ng/ml of IL-1 for the indicated times or pre-treated with 5M
curcumin for the indicated times followed by stimulation with
10 ng/ml of IL-1 for 30 min (Fig. 4A).
IL-1 induced p65 phosphorylation in the nuclear fraction in
a time-dependent manner (Fig. 4A, left panel). Curcumin
blocked IL-1-induced translocation of p65 to the nucleus in a
time-dependent manner (Fig. 4A, right panel). Tenocytes were
either incubated with curcumin at various concentrations for
4 h or preincubated with curcumin at various concentrations
for 4 h followed by 10 ng/ml of IL-1 stimulation for 30 min.
The nuclear extracts were probed for phospho-p65 byWestern
blot analysis (Fig. 4B). Curcumin inhibited IL-1-induced
NF-B activation in a concentration-dependent manner (Fig.
4B, right panel).
PI-3K Signaling Pathway Is Involved in the IL-1-mediated
NF-B Activation in Tenocytes—To examine a possible func-
tional relationship between inhibition of the PI-3K pathway
and suppression of NF-B activation in response to curcumin
treatment, tenocytes were either stimulated with 20 nM wort-
mannin, a specific inhibitor of PI-3K, for the indicated times or
preincubated with 20 nM wortmannin for the indicated times
followed by 10 ng/ml of IL-1 stimulation for 30min. Tenocyte
nuclear protein extracts were probed for the phosphorylated
form of the p65 NF-B subunit (Fig. 5A). In separate experi-
ments, tenocytes were preincubated with wortmannin at the
FIGURE 1. Effect of curcumin on IL-1-induced cellular degeneration and apoptosis in tenocytes. A, electronmicroscopywas performed to demonstrate
the effects of curcumin on IL-1-stimulated tenocytes in monolayer culture. Untreated control tenocytes containing mitochondria, rough endoplasmic
reticulum, andmanyother cell organelles are inpanel a. In contrast, stimulationof tenocyteswith 10ng/ml of IL-1 for 12, 24, and48h resulted indegenerative
changes of the cells. After 12 h, tenocytes became rounded and the nucleus containedmore condensed chromatin (b). After 24 hmultiple vacuoles, swelling
of roughendoplasmic reticulum, andclusteringof swollenmitochondriawasvisible (c). Longer incubationsof 48h led to the formationof apoptoticbodies and
cell lysis (d). However, pre-treatment of IL-1-stimulated tenocytes with curcumin inhibited the adverse effects of IL-1 (e–g) and after 48 h treatment (g)
tenocytes demonstrated large, flattened cellswithnumerousmicrovilli-like processes andmitochondriawere comparablewith control cultures.Bar,1M.B, to
quantify cellular degradation and apoptosis in these cultures, 100 cells from 20microscopic fields were counted. The number of degraded and apoptotic cells
was highest in cultures stimulated with IL-1 alone. In contrast to this, pre-treatment of IL-1-stimulated cultures with curcumin inhibited the cellular
degradation and apoptotic effects of IL-1 and the number of degraded and apoptotic cells remained significantly lower over the entire culture period (*).
Curcumin Inhibits NF-B Signaling in Tenocytes
28560 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 32•AUGUST 12, 2011
indicated concentrations for 4 h followed by co-treatment with
10 ng/ml of IL-1 and wortmannin for 30 min (Fig. 5B). As
shown in Fig. 5, A and B, wortmannin substantially inhibited
IL-1-induced NF-B activation in a time- and concentration-
dependent manner, suggesting that the PI-3K signaling path-
way is functionally involved in the process of IL-1-induced
activation of NF-B. Wortmannin alone had no effect on the
NF-B activation (Fig. 5A, left panel).
Curcumin Inhibits IL-1-dependent IB Degradation and
Phosphorylation—It is well known that an important prerequi-
site for the activation of NF-B is the phosphorylation and deg-
radation of IB, the natural blocker of NF-B (17, 42, 44). To
examine whether the inhibitory activity of curcumin was
through inhibition of IB degradation, cells were treated with
curcumin, followed by IL-1, and subsequently probed for
NF-B expression in the nucleus and IB expression in the
cytoplasm by Western blot analysis. IL-1 induced IB deg-
radation in control cells within 10min but not at all in curcum-
in-treated cells (Fig. 6A, row I). These results indicate that cur-
cumin blocks IL-1-induced IBdegradation.Data shown are
representative of three independent experiments.
Next, we examined whether inhibition of IL-1-induced
IB degradation was through inhibition of IB phosphory-
lation, the tenocytes were treated with curcumin and then with
IL-1 and examined for IBphosphorylation in the cytoplasm
byWestern blot analysis. IL-1-induced IB- phosphorylation
was almost completely blocked by curcumin (Fig. 6A, row II).
Curcumin Inhibits IL-1-induced Nuclear Translocation of
NF-B (p65)—Pro-inflammatory cytokines induce the phos-
phorylation of p65, which is required for NF-B transcriptional
activity. The phosphorylation of NF-B is known to be medi-
ated through IKK (28, 45, 46). In addition, cytoplasmic extracts
were examined for expression of pan-/phospho-p65 (Fig. 6A,
rows III and IV). Western blot analysis confirmed the IL-1-
induced phosphorylation of the cytoplasmic pool of p65 in a
time-dependent manner, and p65 phosphorylation could be
seen as early as 5 min and increased up to 40 min (Fig. 6A, row
IV). Pre-treatment with curcumin inhibited the IL-1-induced
phosphorylation of cytoplasmic p65. IL-1 also induced p65
phosphorylation in the nuclear fraction in a time-dependent
manner, and curcumin blocked IL-1-induced translocation of
p65 to the nucleus (Fig. 6B, rows I and II).
The immunocytochemical analysis confirmed the Western
blot findings that curcumin blocked the translocation of p65
from the cytoplasm to the nucleus. The p65 subunit of NF-B
was localized in the cytoplasm of untreated cells. IL-1 induced
nuclear translocation of p65 and curcumin blocked the trans-
location (Fig. 7).
Effect of Curcumin on IL-1-induced Acetylation of NF-B in
Tenocytes—The acetylation of p65 plays an essential role in
IB-mediated activation ofNF-B transcriptional activity (47,
48). To investigate the effect of curcumin on the acetylation of
p65 by IL-1, human tenocytes were pretreated with curcumin
for 4 h and then exposed to IL-1 for the indicated times.
Whole cell extracts were examined and immunoprecipitated
with anti-p65 antibody, and Western blot analysis was per-
formed using anti-acetyl-lysine antibody. As shown in Fig. 8,
IL-1 induced the acetylation of p65 in a time-dependentman-
ner, and curcumin completely suppressed the IL-1-induced
acetylation of p65 (Fig. 8).
Effect of Curcumin on IL-1-induced Activation of IKK—It
has been shown that IKK is required for TNF-induced Phos-
phorylation of IB (44). We further evaluated the effect of
curcumin on IL-1-induced IKK activation, which is required
for IL-1-induced phosphorylation of IB. The results from
the immune complex kinase assay showed that IL-1 induced
the activation of IKK in a time-dependent manner and that
curcumin blocked IL-1-activated IKK (Fig. 9A, lane I). IL-1
or curcumin had no direct effect on the expression of IKK- or
IKK- proteins (Fig. 9A, lanes II and III).
Next, to examine further whether curcumin blocks IKK
activity directly by binding IKK or indirectly by inhibition of its
activation, human tenocytes were treated with IL-1 or left
untreated. Whole cell extracts from untreated cells and IL-1-
stimulated cells were incubated with anti-IKK- antibody.
After precipitation with protein A/G-Sephadex beads, the
immunocomplexes were exposed with various concentrations
of curcumin. As shown in Fig. 8B, the immunocomplex kinase
assay revealed that curcumin directly suppressed the activity of
IKK (Fig. 9B, row I). IL-1 or curcumin had no direct effect on
the expression of IKK- or IKK- proteins (Fig. 9B, rows II
and III).
Curcumin Blocks IL-1-inducedAkt Stimulation—The stim-
ulation of IKK- is required for the phosphorylation of IB.
Moreover, it has been reported that pro-inflammatory cyto-
FIGURE2.Effectsof curcuminon IL-1-induced inhibitionof extracellular
matrix compounds and signaling proteins expression in tenocytes. To
evaluate the effects of curcumin on IL-1-stimulated tenogenic inhibition in
tenocytes, whole cell lysates (500 ng of protein/lane) were probed with anti-
bodies to collagen type I (CI), collagen type III (CIII), decorin, tenomodulin
(Tnmd), and the tenogenic specific transcription factor SCXA. Serum-starved
human tenocytes (1 106 cells/ml) were exposed to 10 ng/ml of IL-1 alone,
5 M curcumin alone, or were pre-treated with 5 M curcumin for 4 h and
followed either by incubation with IL-1 alone or incubation with IL-1 and
curcumin, or left untreated for 24 h. Each experiment was performed in trip-
licate. Expression of the-actinhousekeepinggenewas not affectedby IL-1
and/or curcumin.
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kine-mediated stimulation of IKK- is associated with an
upstream protein kinase, Akt (serine-threonine kinase, protein
kinase B), and in turn Akt mediates IKK- phosphorylation
(49). To investigate whether curcumin blocks the IL-1-in-
duced IB phosphorylation due to inhibition of Akt, the
serum-starved tenocytes were treatedwith IL-1 (10 ng/ml) for
different indicated times or pre-treated with curcumin (5 M)
for 4 h and then co-treated with IL-1 for the indicated times.
The whole cell extracts were analyzed by Western blotting
using anti-phospho-specific-Akt antibody. As shown in Fig. 10
row I, IL-1 induced activation of Akt in a time-dependent
manner. In contrast, in co-treated tenocytes, curcumin clearly
inhibited the phosphorylation of Akt.
Next, we explored whether curcumin affects the association
of Akt with IKK.Whole cell lysates from human tenocytes pre-
treated with curcumin and co-treated with IL-1 were immu-
FIGURE 3. Effects of curcumin on IL-1-inducedNF-B-dependent pro-inflammatory, anti-apoptotic, and pro-apoptotic gene products in tenocytes.
A, to evaluate whether curcumin exerts effects on IL-1-induced NF-B-dependent expression of pro-inflammatory (COX-2) andmatrix-degrading (MMP-1, -9,
and -13) gene products, serum-starved tenocytes (1 106 cells/ml) were exposed to 10 ng/ml of IL-1 alone, 5M curcumin alone, or were pre-treatedwith 5
M curcumin for 4 h and followed either by incubationwith IL-1 alone or incubationwith IL-1 and curcumin, or left untreated for 24 h. Each experimentwas
performed in triplicate. Expression of the-actinhousekeeping genewas not affected by IL-1 and/or curcumin. B, to determinewhether curcumin treatment
actively stimulates the production of anti-apoptotic geneproducts (Bcl-2, TRAF1, and Bcl-xL), serum-starved human tenocytes (1 106 cells/ml)were exposed
to 10 ng/ml of IL-1 alone, 5 M curcumin alone, or were pre-treated with 5 M curcumin for 4 h and followed either by incubation with IL-1 alone or
incubation with IL-1 and curcumin, or left untreated for 24 h. Synthesis of the -actin housekeeping gene remained unaffected. C, whole cell lysates of
serum-starved human tenocytes (1 106 cells/ml) were exposed to 10 ng/ml of IL-1 alone, 5M curcumin alone, or were pre-treatedwith 5M curcumin for
4 h and followed either by incubation with IL-1 alone or incubation with IL-1 and curcumin, or left untreated and evaluated with Western blot analysis to
examine the effect on the pro-apoptotic proteins Bax and caspase-3. Expression of the housekeeping protein -actin remained unaffected.
FIGURE 4. Curcumin suppression of IL-1-induced NF-B activation.
A, serum-starved human tenocytes (1 106 cells/ml) were either stimulated
with 10 ng/ml of IL-1 for the indicated times or preincubated with 5 M
curcumin for 0, 5, 10, 20, 40, and 60min, co-treatedwith 10 ng/ml of IL-1 for
30 min, and then probed for phospho-p65 by Western blot analysis using
antibodies to phospho-specific p65 and poly(ADP-ribose) polymerase (PARP)
(control). B, serum-starved human tenocytes were either incubated with cur-
cumin at various concentrations (0, 1, 2, 5, 10, and 15 M) for 4 h or preincu-
batedwith curcuminat various concentrations for 4h followedby10ng/mlof
IL-1 stimulation for 30 min. The nuclear extracts (500 ng of protein/lane)
were probed for phospho-p65 by Western blot analysis using antibodies to
phospho-specific p65 and PARP (control). Expression of PARP remained unaf-
fected in the nuclear extracts. The results shown are representative of three
independent experiments.
FIGURE 5. Effect of wortmannin on IL-1-induced NF-B activation.
A, serum-starved human tenocytes (1  106 cells/ml) were either stimulated
with20nMwortmannin for0,5, 10,20,40, and60minorpreincubatedwith20nM
wortmannin for 0, 5, 10, 20, 40, and 60min, co-treatedwith 10 ng/ml of IL-1 for
30min, and thenprobed for phospho-p65byWesternblottingusing antibodies
to phospho-specific p65 and poly(ADP-ribose) polymerase (PARP) (control). B,
serum-starved tenocytes were preincubated with wortmannin at various con-
centrations (0, 1, 10, 20, 30, and 40 nM) for 1 h followed by 10 ng/ml of IL-1
stimulation for 30min. Nuclear extracts (500ngof protein/lane)wereprobed for
phospho-p65byWesternblottingusingantibodies tophospho-specificp65and
PARP (control). Expression of PARP remained unaffected in nuclear extracts. The
results shown are representative of three independent experiments.
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noprecipitated with anti-IKK- antibody followed by Western
blot analysis using anti-Akt antibody. As shown in Fig. 10, row
II, IL-1 induced a combination between IKK- and Akt in a
time-dependent fashion, and this was clearly inhibited by cur-
cumin. Taken together, these results indicate that curcumin
blocks IKK- activation through inhibition of an upstreampro-
tein kinase B (Akt).
Curcumin Modulates IL-1-induced NF-B Activation by
Inhibition of the PI-3K/p85 Signaling Pathway in Tenocytes—
To gain a mechanistic insight into the mode of action of curcu-
min on IL-1-stimulated tenocytes we studied the effects of
curcumin on PI-3K activation using the Akt/IKK assay. Akt is a
well known downstream protein kinase B target of PI-3K, and
its activation ismainly induced by the phosphorylation of Ser or
Thr residues (50). Previous work has shown that the PI-3K sig-
naling pathway is inhibited by curcumin treatment in MCF7
cells (51). Therefore, to investigate whether the effect of curcu-
min on the IL-1-induced Akt phosphorylation is mediated
through inhibition of the PI-3K signaling pathway in human
tenocytes, the serum-starved tenocytes were treatedwith IL-1
(10 ng/ml) for the times indicated or pre-treatedwith curcumin
FIGURE 6. Effect of curcumin on the IL-1-induced phosphorylation and
degradation of IB and the phosphorylation and translocation of p65.
Serum-starved human tenocytes (1 106 cells/ml) were either stimulatedwith
10 ng/ml of IL-1 for the indicated times or pre-treated with 5 M curcumin for
4 h, followed by 10 ng/ml of IL-1 stimulation for the indicated times. Cytoplas-
mic (A) and nuclear extracts (B) were prepared, fractionatedwith SDS-PAGE, and
electrotransferred to nitrocellulose membrane. Western blot analysis was per-
formed with anti-IB, anti-phosphospecific IB, anti-p65, and anti-phospho-
specific p65 antibodies. The results shown are representative of three indepen-
dent experiments. PARP, poly(ADP-ribose) polymerase.
FIGURE 7. Immunocytochemical analysis of p65 localization after treatment with IL-1 as revealed by immunofluorescence microscopy. Tenocyte
cultures either served as controls (not treated) or were treated with IL-1 alone for 10 min or co-treated with 5 M curcumin and 10 ng/ml of IL-1 for 40 min
before immunolabeling with phospho-p65 antibodies and rhodamine-coupled secondary antibodies. Data shown are representative of three independent
experiments. Original magnification,160.
FIGURE 8. Effect of curcumin on IL-1-induced acetylation of p65. Serum-
starved human tenocytes (1  106 cells/ml) were either stimulated with 10
ng/ml of IL-1 for the indicated times or pre-treated with 5 M curcumin for
4 h and then exposed to 10 ng/ml of IL-1. Whole cell extractswere prepared,
immunoprecipitated (IP) with anti-p65 antibody, and subjected to Western
blot analysis using anti-acetyl-lysine antibody. The same blots were
re-probed with anti-p65 antibody. IB, immunoblot.
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(5 M) for 4 h and then co-treated with IL-1. Whole cell
extracts were probed by Western blot analysis using a PI-3K/
p85 subunit antibody. As shown in Fig. 11, row I, IL-1-induced
activation of PI-3K/p85 in a time-dependent manner. In con-
trast, in co-treated tenocytes, curcumin substantially inhibited
the activation of PI-3K/p85. Consistent with this observation,
IL-1 significantly induced Akt phosphorylation, which was
reduced by curcumin in a dose-dependent manner (Fig. 10).
Taken together, these findings suggest that curcumin mediates
its anti-inflammatory effects, at least in part, through modula-
tion of the PI-3K/Akt signaling pathway in human tenocytes.
Expression of the housekeeping protein -actin was unaffected
(Fig. 11, row II).
Suppression of PI-3K Signaling Supports the Inhibitory Effect
of Curcumin—Themechanism involved in curcumin-mediated
inhibition of IL-1-induced NF-B activation in human teno-
cytes was further investigated. It is known that the PI-3K path-
way is required for activation of NF-B by IL-1 and wortman-
nin is a blocker of PI-3K signaling (36). Pre-treatment of
tenocytes with different concentrations of wortmannin (1, 10,
and 20 nM) for 1 h, treated with curcumin (5 M) for 4 h, and
then treated with IL-1 for 1 h, inhibited the IL-1-induced
NF-B activation. The inhibitory effects of wortmannin and
curcumin on IL-1-stimulated human tenocytes appeared to
be synergistic (Fig. 12, row I).
DISCUSSION
The purpose of this study was to investigate the effects of
curcumin on the IL-1-inducedNF-B activation pathway and
NF-B-regulated gene products that influence inflammation
in tendon. Using monolayer-cultured human tenocytes, we
found that curcumin inhibited IL-1-induced NF-B activa-
tion through suppression of IB phosphorylation, IB deg-
radation, IB kinase activity, and NF-B-dependent gene
products involved in inflammation (COX-2), in extracellular
matrix degradation (MMPs), apoptosis (Bcl-2, Bcl-xL, and
TRFA-1), and activation of apoptosis (i.e. activation of caspase-
3). This inhibitionwas correlatedwith suppression of p65 phos-
phorylation, p65 nuclear translocation, and p65 acetylation.
We also demonstrated that the PI-3K/Akt signaling pathway is
activated in response to IL-1 and suppression of IL-1-in-
duced NF-B activation by curcumin appears to involve the
PI-3K/Akt pathway and its association with IKK.
Tendinopathy is accompanied by inflammation and degra-
dation of the tendon extracellular matrix. At a tendon injury
site, pro-inflammatory cytokines such as IL-1 may initiate a
cascade of events leading to tendon destruction and loss of bio-
mechanical structural integrity. Furthermore, besides the up-
regulation of inflammatorymediators, we found that IL-1 sig-
nificantly down-regulates the expression of collagen types I and
III, decorin, and tenomodulin in tenocytes. Thus, IL-1-medi-
ated suppression of collagen type I and other tendon-specific
extracellular matrix compound expression may lead to the
reduced deposition of extracellular matrix and consequently, it
might affect normal tissue remodeling and lead to the develop-
ment of tendinopathy. The control of IL-1 secretion may be
critical for protecting tendons from pathological processes. In
fact, human tenocytes express IL-1 receptors so that the
ligand-receptor signal is transduced via the specific and func-FIGURE 9. A, effects of curcumin treatment on IL-1-induced IB kinase acti-
vation. Serum-starved primary human tenocytes were either stimulatedwith
10 ng/ml of IL-1 for the indicated times or pre-treated with 5 M curcumin
for 4 h and then co-treated with IL-1 (10 ng/ml) for the indicated times.
Whole cell extracts were immunoprecipitated with an antibody against IB
kinase (IKK)- and analyzed by an immune complex kinase assay. To examine
the effect of curcumin on the expression level of IKK proteins, whole cell
extracts (500 ng of protein/lane) were fractionated by SDS-PAGE and exam-
ined using Western blot analysis with anti-IKK- and anti-IKK- antibodies.
Data shown are representative of three independent experiments. B, direct
effect of curcumin treatment on IL-1-induced IB kinase activation. Serum-
starved human tenocytes (1  106 cells/ml) were treated with 10 ng/ml of
IL-1. Whole cell extracts were prepared and immunoprecipitated with anti-
IKK- antibody. The immunocomplex kinase assay was performed in the
absence or presence of curcumin at the indicated concentrations. Data
shown are representative of three independent experiments.
FIGURE 10. Effect of curcumin on IL-1-induced Akt phosphorylation. Serum-starved human tenocytes (1 106 cells/ml) were either stimulated with 10
ng/ml of IL-1 for the indicated times or pre-treated with 5 M curcumin for 4 h and exposed to 10 ng/ml of IL-1 for the indicated times. Whole cell extracts
were analyzed by Western blot analysis using anti-phospho-specific Akt (row I). Cell extracts were immunoprecipitated (IP) with anti-IKK- antibody and the
immunoprecipitates were separated (500 ng of protein/lane) by SDS-PAGE and analyzed by immunoblotting (IB) using anti-Akt antibody (row II) or with
anti-IKK- antibody (row III, as a loading control). Results shown are representative of three independent experiments.
FIGURE 11. Effects of curcumin treatment on IL-1-induced PI-3K/p85.
Serum-starved human tenocytes (1 106 cells/ml) were either stimulated with
10ng/mlof IL-1 for the indicatedtimesorpre-treatedwith5Mcurcuminfor4h
andexposed to10ng/mlof IL-1 for the indicated times.Wholecell extracts (500
ngof protein/lane)were analyzedbyWestern blot analysis using anti-PI-3K/p85.
Expression of the housekeeping protein -actin remained unaffected. Results
shown are representative of three independent experiments.
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tional IL-1 receptor.Moreover, IL-1 activates numerous sig-
nal transduction systems through protein kinases and this
causes induction of genes by activation and suppression of spe-
cific transcription factors such as NF-B (52).
We found that curcumin suppresses the activation of NF-B
in human tenocytes in vitro and inhibits the expression of
NF-B-regulated gene products, including COX-2, MMPs,
Bax, and caspase-3. Curcumin can both stimulate and inhibit
apoptotic signaling, and the treatment time as well as the con-
centration may determine the effects of curcumin on various
cell types (53). Although curcumin has been shown to inhibit
cytokine-induced NF-B activation in many different pri-
mary cells and cell lines of various origins (22, 25, 28, 29,
54–57), to the best of our knowledge, this is the first such
report in human tenocytes.
A possible mechanism underlying the inhibition of inducible
NF-B by curcumin could be its capacity to inhibit the PI-3K
and Akt signaling pathways. Previous studies using other cells
have shown that curcumin inhibits the DNA binding function
ofNF-B through suppression of IB phosphorylation (25, 29,
58). Thus, down-regulation of upstream signaling proteins,
such as PI-3K/Akt, may be involved in curcumin-mediated
activation of IL-1-induced NF-B inhibition in tenocytes. In
fact it has been reported that the PI-3K pathway is required for
activation ofNF-Bby cytokines such as IL-1 (36). Our results
demonstrate that wortmannin, a specific inhibitor of the PI-3K
pathway, inhibits NF-B activation and its translocation in the
nucleus in tenocytes. These observations suggest that the PI-3K
pathway may be involved in IL-1 signaling. Furthermore,
IL-1-induced activation of PI-3K/p85 and Akt could be inhib-
ited clearly by curcumin in human tenocytes. We found that
inhibition of PI-3K/p85 by curcumin, a process required forAkt
activation, inhibits IKK and phosphorylation of both IB and
p65. We have also shown that curcumin stimulates the expres-
sion of several anti-apoptotic proteins that are regulated by
NF-B, including Bcl-2, Bcl-xL, and TRAF1. Curcumin also
inhibits the pro-apoptotic protein caspase-3, the matrix
degrading MMPs, as well as the inflammatory enzyme COX-2.
This is consistent with previous reports that have shown that
NF-B activation requires the PI-3K/Akt signaling pathway
(49, 59, 60) and that curcumin suppresses the expression of
pro-apoptotic proteins (Bax and caspase-3) andmatrix degrad-
ing enzymes (MMPs) and mediators of inflammation (COX-2)
(61, 62). Several groups have demonstrated that curcumin can
also inhibit the two subunits of PI-3K (p110 and p85) and phos-
phorylation of the Akt signaling pathway (63, 64). These find-
ings might explain the anti-inflammatory and anti-apoptotic
effects of curcumin in tenocytes.
It is well known that the tendon-specific transcription factor
SCXA is required for expression of tendon-specific extracellu-
lar matrix genes (65). We also observed a reduction in collagen
type I and SCXA expression in tenocytes after treatment with
IL-1. However, curcumin pre-treatment inhibited the IL-1-
induced down-regulation of collagen type I and SCXA expres-
sion. Thus, curcumin stimulated tenocytes, at least in part,
through activation of the tenogenic transcription factor scler-
axis, enhancing transcription of tendon-associated collagens in
a SCXA-dependent fashion.
Moreover, curcumin did not exert any toxicity on the cells.
Studies on the phase I clinical trials suggest that curcumin can
be orally administered safely at doses of 0.2–12 g/day with no
dose-limiting toxicity, reaching peak serum concentration at
1–2 h (0.51 0.11 M at 4000 mg, 0.63 0.06 M at 6000 mg,
and 1.77  1.87 M at 8000 mg) and is eliminated within 12 h
(30, 31, 66, 67). Recently, a phase II study of this agent has
shown that this compound has biological activity in patients
with pancreatic cancer (68).
Overall, our data suggest that curcumin down-regulates
NF-BandNF-B-regulated gene products involved in apopto-
sis, matrix degradation, and inflammation in human tenocytes
in vitro. These effects are mediated, at least in part, through
down-regulation of PI-3K/Akt signaling. This study provides
additional support for designing anti-inflammatory com-
pounds based on curcumin for diseases mediated through
NF-B activation. Therefore, curcumin might have prophylac-
tic potential for the treatment of tendinitis.
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